title: Which is better in neoadjuvant treatment of breast cancer? Taxane followed by anthracyline or vice versa.
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
authors.forename: Ozden
authors.initials: O
authors.lastname: Altundag
authors.forename: Mauricio Z
authors.initials: MZ
authors.lastname: Baptista
authors.forename: Mustafa A
authors.initials: MA
authors.lastname: Atik
mesh_terms: D018943:Anthracyclines / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D001952:Bridged-Ring Compounds / Q000008:administration & dosage; D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy; D043823:Taxoids / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D018943:Anthracyclines; D001952:Bridged-Ring Compounds; D043823:Taxoids; C080625:taxane